Clinical trial
Memantine for Agitation and Aggression in Severe Alzheimer's Disease
NCT00401167
Study timeline
Study start (unknown)2006-11-01Date precision: month
Registry last updated2024-01-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
memantineDRUG · verified · RxNorm: memantine
Sponsors & collaborators
Sunnybrook Health Sciences Centrelead sponsor
Lundbeck Canada Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00401167 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.